Encompass Health Corporation Amortization of Debt Issuance Costs and Discounts
Encompass Health Corporation (EHC) reported Amortization of Debt Issuance Costs and Discounts of $9.60 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AmortizationOfFinancingCostsAndDiscounts · last filed 2026-02-26
- Encompass Health Corporation amortization of debt issuance costs and discounts for the quarter ending 2012-12-31 was $1.00M, a 11.11% increase year-over-year.
- Encompass Health Corporation amortization of debt issuance costs and discounts for the quarter ending 2011-12-31 was $900.00K, a 25.00% decline year-over-year.
- Encompass Health Corporation amortization of debt issuance costs and discounts for the quarter ending 2010-12-31 was $1.20M, a 33.33% decline year-over-year.
- Encompass Health Corporation amortization of debt issuance costs and discounts for the quarter ending 2009-12-31 was $1.80M.
- Encompass Health Corporation amortization of debt issuance costs and discounts for fiscal 2025 was $9.60M, a 1.03% decline from fiscal 2024.
- Encompass Health Corporation amortization of debt issuance costs and discounts for fiscal 2024 was $9.70M, a 2.11% increase from fiscal 2023.
- Encompass Health Corporation amortization of debt issuance costs and discounts for fiscal 2023 was $9.50M, a 2.06% decline from fiscal 2022.
- Encompass Health Corporation amortization of debt issuance costs and discounts for fiscal 2022 was $9.70M, a 24.36% increase from fiscal 2021.
| Period end | Amortization of Debt Issuance Costs and Discounts 3 month | Amortization of Debt Issuance Costs and Discounts 9 month | Amortization of Debt Issuance Costs and Discounts 12 month |
|---|---|---|---|
| 2025-12-31 | $9.60M 10-K · filed 2026-02-26 | ||
| 2024-12-31 | $9.70M 10-K · filed 2026-02-26 | ||
| 2023-12-31 | $9.50M 10-K · filed 2026-02-26 | ||
| 2022-12-31 | $9.70M 10-K · filed 2025-02-28 | ||
| 2021-12-31 | $7.80M 10-K · filed 2024-02-28 | ||
| 2020-12-31 | $7.20M 10-K · filed 2023-02-27 | ||
| 2019-12-31 | $4.50M 10-K · filed 2022-02-25 | ||
| 2018-12-31 | $4.00M 10-K · filed 2021-02-26 | ||
| 2017-12-31 | $8.70M 10-K · filed 2020-02-27 | ||
| 2016-12-31 | $13.80M 10-K · filed 2019-02-27 | ||
| 2015-12-31 | $14.30M 10-K · filed 2018-02-28 | ||
| 2014-12-31 | $12.70M 8-K · filed 2017-09-19 | ||
| 2013-12-31 | $5.00M 10-K · filed 2016-02-25 | ||
| 2012-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $3.70M 10-K · filed 2015-03-02 | |
| 2012-09-30 | $2.70M 10-Q · filed 2012-10-26 | ||
| 2011-12-31 | $900.00K derived: 8-K 12 month − 10-Q 9 month · filed 2012-09-06 | $4.20M 8-K · filed 2012-09-06 | |
| 2011-09-30 | $3.30M 10-Q · filed 2012-10-26 | ||
| 2010-12-31 | $1.20M derived: 8-K 12 month − 10-Q 9 month · filed 2012-09-06 | $6.30M 8-K · filed 2012-09-06 | |
| 2010-09-30 | $5.10M 10-Q · filed 2011-11-04 | ||
| 2009-12-31 | $1.80M derived: 8-K 12 month − 10-Q 9 month · filed 2012-09-06 | $6.60M 8-K · filed 2012-09-06 | |
| 2009-09-30 | $4.80M 10-Q · filed 2010-11-03 | ||
| 2008-12-31 | $6.50M 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pediatrix Medical Group, Inc. (MD) | United States | $2.084B | 11.76 |